Profiel
Renee F.
Cohen was a Director at Pfizer, Inc. She was Vice President of Operations & Strategy for NeoStem, Inc. until July 24, 2008 and Co-Founder and Chief Operating Officer of DrugVoice from 2000 to 2002.
Ms. Cohen worked at Accenture from1993 to 2000.
She received a Bachelor of Arts degree from Brandeis University in 1988 and an MBA from New York University's Stern School of Business in 1992.
Eerdere bekende functies van Renee F. Cohen
Bedrijven | Functie | Einde |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Operationeel Directeur | 24-07-2008 |
Opleiding van Renee F. Cohen
Brandeis University | Undergraduate Degree |
New York University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |